Citace podle APA

Kozlova, N., Wottawa, M., Katschinski, D. M., Kristiansen, G., & Kietzmann, T. (2016). Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer. Oncotarget.

Styl Chicago

Kozlova, Nina, Marieke Wottawa, Dörthe Magdalena Katschinski, Glen Kristiansen, a Thomas Kietzmann. "Hypoxia-inducible Factor Prolyl Hydroxylase 2 (PHD2) Is a Direct Regulator of Epidermal Growth Factor Receptor (EGFR) Signaling in Breast Cancer." Oncotarget 2016.

Citace podle MLA

Kozlova, Nina, et al. "Hypoxia-inducible Factor Prolyl Hydroxylase 2 (PHD2) Is a Direct Regulator of Epidermal Growth Factor Receptor (EGFR) Signaling in Breast Cancer." Oncotarget 2016.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..